KO vs MS: Which Is the Better Buy?

Side-by-side comparison of The Coca-Cola Company and Morgan Stanley β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-06-20.
The Coca-Cola Company Β· Consumer Defensive
$79.39
-9.9% upside to fair value
Grade D High Quality
VS
Morgan Stanley Β· Financial Services
$223.17
-1802.9% upside to fair value
Grade D High Quality
QuantHub Verdict
KO has more upside to fair value (-9.9%). MS trades at a lower forward P/E (20.1x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric KO MS
Current Price $79.39 $223.17
Fair Value Estimate $71.54 $-3,800.42
Upside to Fair Value -9.9% -1802.9%
Market Cap $341.6B $352.0B
Forward P/E 24.9x 20.1x
EV / EBITDA 19.5x 21.9x
Price / Sales 6.9x 2.9x
Price / FCF 27.2x -334.6x
Revenue Growth YoY +12.1% +18.8%
Gross Margin 61.7% 58.0%
Operating Margin 29.3% 19.5%
Return on Equity 43.6% 16.4%
Dividend Yield 0% 0%
FCF Yield 3.68% β€”
Analyst Consensus Strong Buy Hold
Investment Thesis
KO β€” The Coca-Cola Company
The Coca-Cola Company is a leading global branded beverages company with a very wide moat in sparkling soft drinks and non-alcoholic ready-to-drink beverages. It benefits from strong pricing power, stable margins, and high recurring cash flow, supported by a seasoned management team with deep company tenure. Despite solid recent growth with revenue up 12.1% and earnings up 17.8% in the most recen…
MS β€” Morgan Stanley
Morgan Stanley is a leading global financial services firm with a strong focus on wealth management and institutional securities, generating $70.6 billion in net revenues in 2025. The company benefits from a durable competitive moat driven by its fee-based wealth franchise, strong profitability with a 15.1% net margin, and steady capital returns. However, the stock is significantly overvalued, tr…
Accumulation Zones
Metric KO MS
Zone Low $53.66 $-2,850.32
Zone High $60.81 $-3,230.36
In Buy Zone? No No
← KO Research    MS Research β†’    All Research